SERS-Based Immunoassay for α-Fetoprotein Biomarker Detection Using an Au-Ag Nanostars Platform
Biosensors · 2025
DOI: 10.3390/bios15090632 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors, 2025. Verfasst von Josué Ismael García-Ramírez und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigación en Micro y Nanotecnología, Universidad Veracruzana, Boca del Río 94294, Mexico. Hauptthemen laut MEDLINE: alpha-Fetoproteins, Spectrum Analysis, Raman, Metal Nanoparticles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Secretaría de Ciencia, Humanidades, Tecnología e Innovación (Secihti).
Abstract (Originalsprache)
Spiky Au-Ag nanostars offer intense plasmonic enhancement due to their sharp-tipped morphology, enabling powerful surface-enhanced Raman scattering (SERS). Here, we report a liquid-phase SERS platform that addresses current limitations in cancer biomarker detection, such as low sensitivity and dependence on Raman reporters. Nanostar concentration was tuned by simple centrifugation (10, 30, and 60 min), and their SERS performance was evaluated using methylene blue (MB) and mercaptopropionic acid (MPA) as probe molecules. Signal intensity scaled with nanostar content, enabling sensitive detection. Optimized nanostars were functionalized with MPA, 1-Ethyl-3-(3-dimethylamino1-Ethyl-3-(3dimethylaminopropyl1) carbodiimide (EDC), and N-Hydroxy succinimide (NHS) for covalent attachment of monoclonal anti-α-fetoprotein antibodies (AFP-Ab), facilitating the detection of AFP antigens across 167–38 ng/mL (antibody) and 500–0 ng/mL (antigen) ranges. The limit of detection (LOD) for the antigens was determined to be 16.73 ng/mL. Unlike conventional SERS systems, this aqueous, surfactant-free platform exploits the intrinsic vibrational modes of AFP, enabling sensitive and rapid biomarker detection with strong potential for early cancer diagnostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centro de Investigación en Micro y Nanotecnología, Universidad Veracruzana, Boca del Río 94294, Mexico.
- Facultad de Bioanálisis, Universidad Veracruzana, Veracruz 91700, Mexico.
- Instituto de Ciencias de la Salud, Universidad Veracruzana, Xalapa-Enriquez 91190, Mexico.
- Instituto de Investigaciones Médico Biológicas, Universidad Veracruzana, Veracruz 91700, Mexico.
ORCID-Profile: Irma Yadira Izaguirre-Hernández, Julián Hernández-Torres, Enrique Juárez-Aguilar, Pablo Thomas-Dupont, Luis Zamora-Peredo
Förderung
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación (Secihti)
Zitieren
APA
García-Ramírez, J. I., Luna-Cervantes, M., Izaguirre-Hernández, I. Y., Hernández-Torres, J., Juárez-Aguilar, E., Thomas-Dupont, P., Remes-Troche, J. M., & Zamora-Peredo, L. (2025). SERS-Based Immunoassay for α-Fetoprotein Biomarker Detection Using an Au-Ag Nanostars Platform. Biosensors. https://doi.org/10.3390/bios15090632
Vancouver
García-Ramírez JI, Luna-Cervantes M, Izaguirre-Hernández IY, Hernández-Torres J, Juárez-Aguilar E, Thomas-Dupont P, et al. SERS-Based Immunoassay for α-Fetoprotein Biomarker Detection Using an Au-Ag Nanostars Platform. Biosensors. 2025. doi:10.3390/bios15090632
BibTeX
@article{GarcaRamrez2025,
author = {García-Ramírez, Josué Ismael and Luna-Cervantes, Marcos and Izaguirre-Hernández, Irma Yadira and Hernández-Torres, Julián and Juárez-Aguilar, Enrique and Thomas-Dupont, Pablo and Remes-Troche, José María and Zamora-Peredo, Luis},
title = {SERS-Based Immunoassay for α-Fetoprotein Biomarker Detection Using an Au-Ag Nanostars Platform},
journal = {Biosensors},
year = {2025},
doi = {10.3390/bios15090632}
}
EUVIMED